Financial Tearsheet






Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Chart

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

31 May 23
Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow
Plans to Exit Existing U.S. hemp-derived CBD Operations Intends to Launch Lord Jones ® Brand in the Canadian Adult-use Market in Q4 2023 TORONTO, May 31, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company,
30 May 23
Cronos Group Inc. to Speak at Bernstein's 39th Annual Strategic Decisions Conference
TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at Bernstein's 39th Annual Strategic Decisions Conference on
12 May 23
Cronos Group Inc. to Speak at the Canaccord Genuity 7th Annual Global Cannabis Conference
TORONTO, May 12, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the Canaccord Genuity 7 th Annual Global Cannabis Conference

SEC Filings

Filing date Description

Statement of changes in beneficial ownership of securities

Initial filing by director officer or owner of more than ten percent.

Specialized Disclosure Report

Events

01 June 2023 at 1:30 PM EDT
Bernstein's 39th Annual Strategic Decisions Conference
18 May 2023 at 11:00 AM EDT
Canaccord Genuity 7th Annual Global Cannabis Conference
09 May 2023 at 8:30 AM EDT
Cronos Group First Quarter 2023 Earnings Conference Call